Are All Exosome Products the Same?

If two products are both advertised as “exosomes,” are they basically the same thing?

No.

Products sold under the exosome or extracellular-vesicle category can differ in where they come from, how they're produced, how they're characterized, how many particles they contain, how they're stored, and how much information the manufacturer provides about them.

That's why comparing exosome products based on price or particle count alone can be misleading.

Here are some of the differences buyers should understand.

1. They Can Come From Different Sources

One of the first questions to ask is:

Where did the extracellular vesicles come from?

EVs can originate from different biological sources, including cultured cells and biological fluids—a comparison we cover in where exosomes come from.

And source matters.

Research has shown differences in EV composition between different cell sources. In one comparative study, for example, researchers found differences in the protein and lipid composition of EV populations produced by different cell types.

That doesn't mean one source is automatically better than another.

It means “exosomes” doesn't describe the whole product.

According to KWEHEALTH-supplied information, HydroKarma is produced from refined human amniotic fluid rather than cultured-cell expansion.

That's fundamentally different from a product manufactured by growing cells in culture and collecting EVs from the resulting material.

2. The Manufacturing Process Can Be Different

Source is only the beginning.

How material is processed, separated and prepared can also differ between products.

For cultured-cell-derived EV products, factors such as the cell source and cell expansion can influence the resulting EV preparation. A 2024 study, for example, found differences associated with both MSC tissue source and passage number under the experimental conditions studied. Our guide to cell passage number in exosome manufacturing explains why that applies to cultured-cell products specifically.

Different isolation approaches can also produce preparations with different characteristics.

So two products that eventually receive similar-looking labels may have arrived there through very different processes.

3. The Particle Number Doesn't Tell the Whole Story

Suppose you're comparing:

Product A — 50 billion particles

and

Product B — 100 billion particles.

Is Product B automatically twice as good?

No.

Particle measurements tell you something important, but they don't tell you everything about the preparation.

You also need to consider questions such as:

• How was the particle count measured?
• What size distribution was reported?
• What other characterization was performed?
• Is the number tied to actual batch documentation?

As we've discussed in our 50 Billion vs. 100 Billion Exosomes guide, a larger number by itself doesn't establish identity, purity, quality or superiority.

4. The Amount of Characterization Can Be Very Different

One company might advertise a particle number.

Another may provide particle quantity plus size information, EV-associated markers, analytical methods and additional finished-product testing.

Those aren't equivalent levels of information.

Modern EV guidance emphasizes using multiple approaches to characterize extracellular-vesicle preparations rather than expecting one measurement to answer every question—the principle behind how you know an exosome product actually contains exosomes.

For a buyer, the principle is much simpler:

Look at the evidence behind the label.

5. The Documentation Can Be Different

Two companies may both say:

“Lab tested.”

That doesn't mean they provide the same level of transparency.

• Can you see a Certificate of Analysis?
• Does it identify a particular lot?
• Does it contain actual results?
• Does it tell you how important measurements were made?
• Can you identify the manufacturer?

These questions help distinguish a marketing claim from documentation you can actually evaluate.

Our guide What Should Be on an Exosome Certificate of Analysis? explains what buyers can look for without requiring a scientific background.

6. Even the Product Format Can Be Different

Not every exosome product arrives in the same form.

Some EV products are supplied as frozen liquids.

Others are lyophilized, or freeze-dried, and require reconstitution.

Neither format is automatically superior.

Each creates different formulation, storage and handling considerations.

That's why the relevant question isn't simply:

“Liquid or freeze-dried?”

It's:

“What evidence supports the storage and handling requirements for this particular product?”

We cover that comparison separately in Liquid vs. Lyophilized Exosomes: What's the Difference?

7. Storage and Shipping Can Be Different

How the product gets from the manufacturer to you matters too.

Some products may require controlled frozen storage and cold-chain transportation. Other formulations may have different validated storage requirements. Our cold-chain storage guide explains what that involves.

According to KWEHEALTH-supplied information, HydroKarma is maintained under its specified frozen-storage conditions and shipped overnight on dry ice through manufacturer-managed fulfillment.

That doesn't mean frozen shipping automatically makes a product better.

It means handling requirements are another characteristic you should understand when comparing products.

What Makes HydroKarma Different?

Rather than simply saying “our exosomes are better,” we think buyers should be able to see the differences for themselves.

For HydroKarma, KWEHEALTH provides information regarding the product's amniotic-fluid source, manufacturing pathway, particle characterization, batch-specific testing, storage requirements and fulfillment process.

For example, documentation for HydroKarma lot KH-0007DE reports 50 billion EV per 3 mL vial, particle-size measurements, CD9/CD63/CD81 results and additional finished-product testing.

Those results are specific to that documented lot.

They don't establish that HydroKarma is clinically superior to another EV product.

They give buyers information they can actually evaluate.

And that's the bigger point.

The Bottom Line

No, all exosome products are not the same.

Two products can have the word “exosomes” on the label—and even advertise similar particle counts—while differing in:

source, manufacturing approach, characterization, testing, documentation, formulation, storage and fulfillment.

That doesn't mean you can determine which product is better from any one of those differences alone.

Instead of asking only:

“How many billion exosomes do I get?”

ask:

“What exactly am I buying, where did it come from, and what evidence supports what's being claimed about it?”

Those questions make it much easier to compare products intelligently—and our checklists for questions to ask an exosome supplier and evaluating an exosome product before you buy are a practical place to start.